Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

This study has been completed.
Sponsor:
Collaborators:
Baxter BioScience
Information provided by:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00299988
First received: March 3, 2006
Last updated: November 8, 2010
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)